| immune effector process | GO:0002252 | 321 | 0.698 | |
| defense response to other organism | GO:0098542 | 197 | 0.599 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.598 | |
| cellular response to interferon alpha | GO:0035457 | 4 | 0.589 | |
| defense response to virus | GO:0051607 | 68 | 0.558 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.497 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.423 | |
| regulation of cell activation | GO:0050865 | 289 | 0.391 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.361 | Human |
| viral process | GO:0016032 | 41 | 0.339 | Human |
| negative regulation of immune system process | GO:0002683 | 209 | 0.328 | |
| regulation of defense response to virus by host | GO:0050691 | 8 | 0.301 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.298 | |
| activation of immune response | GO:0002253 | 138 | 0.283 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.258 | |
| negative regulation of nlrp3 inflammasome complex assembly | GO:1900226 | 2 | 0.241 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.239 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.238 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.235 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.222 | |
| activation of innate immune response | GO:0002218 | 56 | 0.217 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.214 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.213 | |
| innate immune response | GO:0045087 | 157 | 0.190 | Human |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.188 | |
| negative regulation of toll like receptor signaling pathway | GO:0034122 | 14 | 0.180 | |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.180 | |
| positive regulation of viral genome replication | GO:0045070 | 2 | 0.177 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.170 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.165 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.164 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.162 | |
| amine metabolic process | GO:0009308 | 45 | 0.155 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.153 | |
| cytokine production | GO:0001816 | 319 | 0.152 | |
| ear development | GO:0043583 | 200 | 0.144 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.143 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.140 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.140 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.140 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.135 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.135 | |
| regulation of defense response | GO:0031347 | 233 | 0.134 | |
| positive regulation of t cell mediated cytotoxicity | GO:0001916 | 15 | 0.130 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.129 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.127 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.125 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.123 | |
| actin filament polymerization | GO:0030041 | 44 | 0.120 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.119 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.118 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.117 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.116 | |
| regulation of interferon beta production | GO:0032648 | 13 | 0.115 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.113 | |
| protein catabolic process | GO:0030163 | 221 | 0.112 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.108 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.107 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.107 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.105 | |
| t cell activation | GO:0042110 | 289 | 0.105 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.104 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.104 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.103 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.102 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.102 | Human |
| lymphocyte differentiation | GO:0030098 | 242 | 0.100 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.098 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.094 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.093 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.091 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.091 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.091 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.091 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.091 | |
| positive regulation of viral entry into host cell | GO:0046598 | 3 | 0.090 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.087 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.086 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.084 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.083 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.083 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.082 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.082 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.082 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.080 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.080 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.077 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.077 | |
| interferon beta production | GO:0032608 | 16 | 0.077 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.077 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.076 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.076 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.075 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.074 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.074 | |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.074 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.074 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.074 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.073 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.073 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.072 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.072 | |
| cell adhesion | GO:0007155 | 329 | 0.072 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.071 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.071 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.071 | |
| interferon beta biosynthetic process | GO:0045350 | 4 | 0.071 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.070 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.070 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.069 | |
| b cell activation | GO:0042113 | 161 | 0.069 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.069 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.068 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.067 | |
| protein polymerization | GO:0051258 | 57 | 0.066 | |
| microtubule based process | GO:0007017 | 236 | 0.066 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.065 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.065 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.064 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.063 | Human |
| response to interferon beta | GO:0035456 | 22 | 0.063 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.063 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.062 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.062 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.062 | |
| viral genome replication | GO:0019079 | 17 | 0.062 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.061 | Human |
| regulation of interferon beta biosynthetic process | GO:0045357 | 4 | 0.061 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.060 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.060 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.060 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.059 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.059 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.059 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.057 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.057 | Human |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.056 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.056 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.056 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.055 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.055 | |
| regulation of cd8 positive alpha beta t cell proliferation | GO:2000564 | 1 | 0.055 | |
| ossification | GO:0001503 | 216 | 0.055 | |
| response to interferon alpha | GO:0035455 | 7 | 0.054 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.054 | |
| regulation of cell migration | GO:0030334 | 219 | 0.054 | Human |
| adaptive immune response | GO:0002250 | 155 | 0.054 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.053 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.052 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.052 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.052 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.052 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.051 | |
| organelle assembly | GO:0070925 | 177 | 0.051 | |
| pallium development | GO:0021543 | 120 | 0.051 | |
| t cell proliferation | GO:0042098 | 120 | 0.051 | |
| regulation of cd8 positive alpha beta t cell activation | GO:2001185 | 3 | 0.051 | |
| regulation of toll like receptor signaling pathway | GO:0034121 | 20 | 0.051 | |
| regulation of rig i signaling pathway | GO:0039535 | 2 | 0.051 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.050 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.050 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.049 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.048 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.047 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.047 | |
| negative regulation of defense response to virus by host | GO:0050689 | 1 | 0.047 | |
| entry into cell of other organism involved in symbiotic interaction | GO:0051806 | 15 | 0.047 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.046 | |
| cell killing | GO:0001906 | 67 | 0.046 | |
| endocytosis | GO:0006897 | 168 | 0.045 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.045 | |
| interferon gamma production | GO:0032609 | 67 | 0.045 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.045 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.045 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.044 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.044 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.044 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.043 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.043 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.043 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.043 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.042 | |
| protein localization to organelle | GO:0033365 | 185 | 0.042 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.042 | Human |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.042 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.042 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.041 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.041 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.041 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.040 | |
| intracellular protein transport | GO:0006886 | 204 | 0.040 | Human |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.040 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.040 | |
| protein processing | GO:0016485 | 163 | 0.040 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.039 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.039 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.039 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.038 | |
| negative regulation of viral release from host cell | GO:1902187 | 6 | 0.038 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.038 | |
| positive t cell selection | GO:0043368 | 23 | 0.037 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.037 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.036 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.036 | Human |
| positive regulation of cell activation | GO:0050867 | 158 | 0.036 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.036 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.035 | Human |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.035 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.035 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.035 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.035 | |
| protein maturation | GO:0051604 | 176 | 0.035 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.035 | |
| protein oligomerization | GO:0051259 | 67 | 0.035 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.035 | Human |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.034 | |
| positive regulation of actin filament polymerization | GO:0030838 | 26 | 0.034 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.034 | |
| gtp catabolic process | GO:0006184 | 143 | 0.034 | |
| positive regulation of t cell mediated immunity | GO:0002711 | 24 | 0.034 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.034 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.034 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.034 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.034 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.034 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.033 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.033 | |
| methylation | GO:0032259 | 134 | 0.033 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.032 | |
| mapk cascade | GO:0000165 | 281 | 0.032 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.032 | |
| defense response to bacterium | GO:0042742 | 119 | 0.031 | |
| natural killer cell proliferation | GO:0001787 | 3 | 0.031 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.031 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.031 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.031 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.031 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.031 | |
| protein import | GO:0017038 | 101 | 0.031 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.031 | Human |
| regulation of protein processing | GO:0070613 | 96 | 0.030 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.030 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.030 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.030 | |
| t cell differentiation | GO:0030217 | 174 | 0.030 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.030 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.030 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.030 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.030 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.030 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.029 | |
| negative regulation of viral genome replication | GO:0045071 | 10 | 0.029 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.029 | Human |
| protein import into nucleus | GO:0006606 | 95 | 0.029 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.029 | Mouse |
| regulation of cell killing | GO:0031341 | 40 | 0.029 | |
| regulation of myd88 dependent toll like receptor signaling pathway | GO:0034124 | 2 | 0.029 | |
| regulation of natural killer cell activation | GO:0032814 | 22 | 0.029 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.029 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.029 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.029 | |
| neuron migration | GO:0001764 | 122 | 0.028 | |
| viral life cycle | GO:0019058 | 36 | 0.028 | Human |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.028 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.028 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.028 | |
| negative regulation of viral entry into host cell | GO:0046597 | 10 | 0.028 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.028 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.028 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.028 | |
| stem cell differentiation | GO:0048863 | 268 | 0.028 | |
| digestive system development | GO:0055123 | 200 | 0.028 | |
| negative regulation of interferon beta production | GO:0032688 | 3 | 0.027 | |
| regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway | GO:0039531 | 2 | 0.027 | |
| regulation of protein binding | GO:0043393 | 60 | 0.027 | |
| single organism nuclear import | GO:1902593 | 95 | 0.027 | |
| regulation of type i interferon mediated signaling pathway | GO:0060338 | 7 | 0.027 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.027 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.027 | Mouse |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.027 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.027 | |
| gland development | GO:0048732 | 330 | 0.027 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.027 | |
| defense response to protozoan | GO:0042832 | 25 | 0.027 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.027 | |
| gtp metabolic process | GO:0046039 | 144 | 0.026 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.026 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.026 | |
| negative regulation of response to biotic stimulus | GO:0002832 | 10 | 0.026 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.026 | |
| membrane fusion | GO:0061025 | 38 | 0.026 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 49 | 0.026 | |
| cell division | GO:0051301 | 120 | 0.026 | |
| chromatin organization | GO:0006325 | 206 | 0.026 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.026 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.026 | |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.026 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.026 | Mouse |
| negative regulation of interferon beta biosynthetic process | GO:0045358 | 1 | 0.025 | |
| cellular response to lipid | GO:0071396 | 145 | 0.025 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.025 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.025 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.024 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.024 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.024 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.024 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.024 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.024 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.024 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.024 | Human |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.024 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.024 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.024 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.023 | |
| skin development | GO:0043588 | 220 | 0.023 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.023 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.023 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.023 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.023 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.023 | |
| syncytium formation | GO:0006949 | 43 | 0.023 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib | GO:0002476 | 4 | 0.023 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.023 | Human |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.023 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | Human |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.022 | |
| t cell selection | GO:0045058 | 34 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.022 | |
| alpha beta t cell proliferation | GO:0046633 | 21 | 0.022 | |
| type i interferon production | GO:0032606 | 29 | 0.022 | |
| multicellular organism growth | GO:0035264 | 161 | 0.022 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 22 | 0.022 | |
| stem cell development | GO:0048864 | 219 | 0.022 | |
| chemotaxis | GO:0006935 | 247 | 0.022 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.022 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.022 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.022 | |
| histone modification | GO:0016570 | 159 | 0.022 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.022 | |
| telencephalon development | GO:0021537 | 186 | 0.022 | |
| regulation of viral genome replication | GO:0045069 | 13 | 0.022 | |
| nuclear membrane organization | GO:0071763 | 4 | 0.021 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.021 | |
| type i interferon signaling pathway | GO:0060337 | 10 | 0.021 | |
| neuron projection guidance | GO:0097485 | 141 | 0.021 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.021 | |
| actin filament organization | GO:0007015 | 113 | 0.021 | |
| glial cell differentiation | GO:0010001 | 131 | 0.021 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.021 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.021 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.021 | |
| regulation of protein localization | GO:0032880 | 231 | 0.021 | Human |
| homeostasis of number of cells | GO:0048872 | 210 | 0.021 | |
| response to interferon gamma | GO:0034341 | 34 | 0.021 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.021 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.020 | |
| regulation of binding | GO:0051098 | 111 | 0.020 | Human |
| muscle tissue development | GO:0060537 | 308 | 0.020 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.020 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.020 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.020 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.020 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.020 | |
| negative regulation of regulatory t cell differentiation | GO:0045590 | 2 | 0.020 | |
| dephosphorylation | GO:0016311 | 129 | 0.020 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.020 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.020 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.020 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.020 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.020 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.020 | |
| hair follicle development | GO:0001942 | 85 | 0.020 | |
| membrane organization | GO:0061024 | 245 | 0.020 | |
| regulation of immunological synapse formation | GO:2000520 | 2 | 0.019 | |
| viral gene expression | GO:0019080 | 3 | 0.019 | Human |
| regulation of ossification | GO:0030278 | 112 | 0.019 | |
| cell maturation | GO:0048469 | 127 | 0.019 | |
| citrate metabolic process | GO:0006101 | 3 | 0.019 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.019 | |
| nuclear transport | GO:0051169 | 139 | 0.019 | Human |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.019 | |
| protein targeting | GO:0006605 | 143 | 0.019 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 34 | 0.019 | |
| hair follicle cell proliferation | GO:0071335 | 3 | 0.019 | |
| natural killer cell activation | GO:0030101 | 44 | 0.019 | |
| regulation of secretion | GO:0051046 | 274 | 0.018 | |
| interaction with host | GO:0051701 | 22 | 0.018 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.018 | Human |
| positive regulation of protein complex assembly | GO:0031334 | 45 | 0.018 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.018 | |
| cell fate commitment | GO:0045165 | 210 | 0.018 | |
| forebrain development | GO:0030900 | 302 | 0.018 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.018 | |
| protein methylation | GO:0006479 | 81 | 0.018 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.018 | |
| muscle cell development | GO:0055001 | 133 | 0.018 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.018 | |
| cell growth | GO:0016049 | 130 | 0.017 | |
| dna metabolic process | GO:0006259 | 303 | 0.017 | Human |
| regulation of protein transport | GO:0051223 | 163 | 0.017 | Human |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.017 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.017 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.017 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.017 | |
| nuclear import | GO:0051170 | 95 | 0.017 | |
| protein alkylation | GO:0008213 | 81 | 0.017 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.017 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.017 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.017 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.017 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.017 | |
| oocyte axis specification | GO:0007309 | 2 | 0.017 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.016 | |
| positive regulation of type i interferon production | GO:0032481 | 14 | 0.016 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.016 | Human |
| cerebral cortex development | GO:0021987 | 86 | 0.016 | |
| positive regulation of t cell receptor signaling pathway | GO:0050862 | 4 | 0.016 | |
| regulation of viral release from host cell | GO:1902186 | 6 | 0.016 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.016 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.016 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.016 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.016 | |
| mast cell proliferation | GO:0070662 | 4 | 0.016 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.016 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.016 | |
| synaptic transmission | GO:0007268 | 329 | 0.016 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.016 | |
| digestive tract development | GO:0048565 | 190 | 0.015 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.015 | |
| protein ubiquitination | GO:0016567 | 171 | 0.015 | |
| macromolecule methylation | GO:0043414 | 120 | 0.015 | |
| interleukin 6 production | GO:0032635 | 58 | 0.015 | |
| negative regulation of growth | GO:0045926 | 99 | 0.015 | |
| myosin filament organization | GO:0031033 | 3 | 0.015 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.015 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.015 | |
| regulation of translation | GO:0006417 | 71 | 0.015 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.015 | |
| protein acylation | GO:0043543 | 64 | 0.015 | |
| b cell differentiation | GO:0030183 | 78 | 0.015 | |
| interleukin 8 production | GO:0032637 | 4 | 0.015 | |
| positive regulation of rac gtpase activity | GO:0032855 | 14 | 0.015 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.015 | Human |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.015 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.015 | |
| germ cell development | GO:0007281 | 185 | 0.015 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.015 | |
| cellular response to type i interferon | GO:0071357 | 10 | 0.015 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.015 | |
| immunoglobulin production | GO:0002377 | 73 | 0.015 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.015 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.015 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.015 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.015 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.015 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.014 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.014 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.014 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.014 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.014 | |
| compound eye development | GO:0048749 | 1 | 0.014 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.014 | |
| negative regulation of defense response to virus | GO:0050687 | 6 | 0.014 | |
| myd88 independent toll like receptor signaling pathway | GO:0002756 | 3 | 0.014 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.014 | |
| t cell lineage commitment | GO:0002360 | 13 | 0.014 | |
| cd8 positive alpha beta t cell differentiation | GO:0043374 | 9 | 0.014 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.014 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.014 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.014 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.014 | |
| neuromuscular process | GO:0050905 | 99 | 0.014 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.014 | |
| synapse organization | GO:0050808 | 125 | 0.014 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.014 | |
| gliogenesis | GO:0042063 | 141 | 0.014 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.013 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | Human |
| negative regulation of binding | GO:0051100 | 39 | 0.013 | Human |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.013 | |
| regulation of myeloid dendritic cell activation | GO:0030885 | 5 | 0.013 | |
| iron ion import into cell | GO:0097459 | 4 | 0.013 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.013 | |
| glucose homeostasis | GO:0042593 | 128 | 0.013 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.013 | |
| lipid localization | GO:0010876 | 126 | 0.013 | |
| cd4 positive alpha beta t cell lineage commitment | GO:0043373 | 6 | 0.013 | |
| response to dsrna | GO:0043331 | 30 | 0.013 | |
| endomembrane system organization | GO:0010256 | 147 | 0.013 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.013 | |
| circulatory system process | GO:0003013 | 197 | 0.013 | |
| entry into other organism involved in symbiotic interaction | GO:0051828 | 15 | 0.013 | |
